title: Effect of hemoglobin solution on compensation to anemia in the erythrocyte-free primate.
abstract: Hemoglobin solutions are undergoing clinical trials as erythrocyte substitutes. Some of these solutions have higher O2 affinities compared with normal erythrocyte hemoglobin. Also, they appear to interact with endothelial-derived smooth muscle relaxation. The purpose of this study was to evaluate the nature and limits of compensation to acute normovolemic anemia in the erythrocyte-free primate maintained with a hemoglobin solution. The experimental group consisted of six anesthetized paralyzed adult baboons (Papio anubis) that were exchange transfused (ET) with a pyridoxylated polymerized hemoglobin solution [hemoglobin concentration [( Hb]) = 14 g/dl, O2 half-saturation pressure of hemoglobin (P50) = 19.6 Torr] until a hematocrit less than 1% was achieved. They underwent a second ET with Dextran-70 until [Hb] = 1 g/dl. A control group (n = 6) underwent an ET with Dextran-70 until [Hb] = 1 g/dl. Both groups maintained O2 consumption (VO2) until [Hb] = 3 g/dl. Both groups were stable until [Hb] less than 1 g/dl, and both groups increased their cardiac output. The relation between VO2 and O2 delivery was similar for both groups. In vivo P50 and mixed venous O2 tension were significantly lower in the experimental group. The nature and limits of compensation to diminished O2 delivery due to anemia were similar in the two groups.
authors.affiliation: Department of Surgery, Michael Reese Hospital and Medical Center, Chicago, Illinois.
authors.forename: A L
authors.initials: AL
authors.lastname: Rosen
authors.forename: S A
authors.initials: SA
authors.lastname: Gould
authors.forename: L R
authors.initials: LR
authors.lastname: Sehgal
authors.forename: H L
authors.initials: HL
authors.lastname: Sehgal
authors.forename: H D
authors.initials: HD
authors.lastname: Levine
authors.forename: R D
authors.initials: RD
authors.lastname: DeWoskin
authors.forename: G S
authors.initials: GS
authors.lastname: Moss
mesh_terms: D000740:Anemia / Q000097:blood / Q000503:physiopathology / Q000628:therapy*; D000818:Animals; D001802:Blood Substitutes / Q000008:administration & dosage / Q000627:therapeutic use*; D002302:Cardiac Output; D005069:Evaluation Studies as Topic; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006454:Hemoglobins / Q000008:administration & dosage / Q000378:metabolism; D010100:Oxygen / Q000097:blood; D010215:Papio; D012996:Solutions
chemical_list: D001802:Blood Substitutes; D006454:Hemoglobins; D012996:Solutions; D010100:Oxygen